Validation of the 2023 FIGO staging schema for advanced endometrial cancer
European Journal of Cancer · 2023-11 · 193 · 113316
DOI: 10.1016/j.ejca.2023.113316 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Journal of Cancer, 2023-11. Verfasst von Koji Matsuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA; Norris Comprehens…. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA,…
- Department of Obstetrics and Gynecology, University of Freiburg Faculty of Medicine, Freiburg, Germany.
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA.
Zitieren
APA
Matsuo, K., Klar, M., Song, B. B., Roman, L. D., & Wright, J. D. (2023). Validation of the 2023 FIGO staging schema for advanced endometrial cancer. European Journal of Cancer, 193, 113316. https://doi.org/10.1016/j.ejca.2023.113316
Vancouver
Matsuo K, Klar M, Song BB, Roman LD, Wright JD. Validation of the 2023 FIGO staging schema for advanced endometrial cancer. European Journal of Cancer. 2023;193:113316. doi:10.1016/j.ejca.2023.113316
BibTeX
@article{Matsuo2023,
author = {Matsuo, Koji and Klar, Maximilian and Song, Bonnie B and Roman, Lynda D and Wright, Jason D},
title = {Validation of the 2023 FIGO staging schema for advanced endometrial cancer},
journal = {European Journal of Cancer},
year = {2023},
volume = {193},
pages = {113316},
doi = {10.1016/j.ejca.2023.113316}
}
EUVIMED